Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Solifenacin (5mg)
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹330/-
Empowering Bladder Control with Precision: The Uropair Approach Soliturn 5 (Solifenacin Succinate 5mg) represents the pinnacle of our Uropair division's commitment to specialized urological care. As a selective muscarinic M3 receptor antagonist, Soliturn 5 is specifically engineered to address the complexities of Overactive Bladder (OAB). By targeting the detrusor muscle’s stability, it provides a clinical solution for patients struggling with involuntary contractions, effectively reducing the daily burden of urinary urgency and frequenc
Empowering Bladder Control with Precision: The Uropair Approach
Soliturn 5 (Solifenacin Succinate 5mg) represents the pinnacle of our Uropair division's commitment to specialized urological care. As a selective muscarinic M3 receptor antagonist, Soliturn 5 is specifically engineered to address the complexities of Overactive Bladder (OAB). By targeting the detrusor muscle’s stability, it provides a clinical solution for patients struggling with involuntary contractions, effectively reducing the daily burden of urinary urgency and frequenc
At Cafoli Lifecare, we understand that urology requires a higher standard of purity and efficacy. That is why Soliturn 5 is manufactured in world-class WHO-GMP certified facilities, ensuring that every tablet delivers consistent pharmacokinetic performance. For our PCD Pharma partners, Soliturn 5 offers a high-demand, monopoly-based molecule that strengthens any urology portfolio. Key Therapeutic Indications: Management of urge incontinence. Reduction of increased urinary frequency (pollakisuria). Treatment of urgency symptoms associated with OAB syndrome. By integrating Soliturn 5 into your practice or distribution network, you are choosing a product backed by transparent ethical policies and the specialized expertise of the Uropair division—where nephrology and urology meet advanced pharmaceutical science.
At Cafoli Lifecare, we understand that urology requires a higher standard of purity and efficacy. That is why Soliturn 5 is manufactured in world-class WHO-GMP certified facilities, ensuring that every tablet delivers consistent pharmacokinetic performance. For our PCD Pharma partners, Soliturn 5 offers a high-demand, monopoly-based molecule that strengthens any urology portfolio.
Key Therapeutic Indications:
Management of urge incontinence.
Reduction of increased urinary frequency (pollakisuria).
Treatment of urgency symptoms associated with OAB syndrome.
By integrating Soliturn 5 into your practice or distribution network, you are choosing a product backed by transparent ethical policies and the specialized expertise of the Uropair division—where nephrology and urology meet advanced pharmaceutical science.
Common side effects may include dry mouth, constipation, blurred vision, and urinary retention. Consult a doctor if severe side effects occur.
Soliturn 5 Tablet is indicated for the treatment of overactive bladder syndrome with symptoms such as urinary urgency, frequency, and incontinence.
Use with caution in patients with a history of urinary retention, glaucoma, or gastrointestinal disorders. Consult your healthcare provider before use if pregnant or breastfeeding.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Composition : Solifenacin (10mg) Tablet
Composition : Mirabegron (50mg) + Solifenacin (5mg)
Composition : Mirabegron (50mg)
Composition : Mirabegron (25mg)
Composition : Ivermectin (6mg) + Albendazole (400mg)
Composition : Ivermectin (12mg) Tablet
Composition : Isoxsuprine (40mg) Tablet
Composition : Tofacitinib (5mg)
Composition : Leflunomide (20mg)
Composition : Leflunomide (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation